Capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer: A phase III trial (CAPItello-290) Meeting Abstract


Authors: Schmid, P.; Cortes, J.; Robson, M.; Iwata, H.; Hegg, R.; Verma, S.; Nechaeva, M.; Xu, B.; Haddad, V.; Imedio, E. R.; Schiavon, G.; Foxley, A.; Park, Y. H.
Abstract Title: Capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer: A phase III trial (CAPItello-290)
Meeting Title: 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 80
Issue: 4 Suppl.
Meeting Dates: 2019 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-02-01
Language: English
ACCESSION: WOS:000527012500134
DOI: 10.1158/1538-7445.Sabcs19-ot2-08-02
PROVIDER: wos
Notes: Meeting Abstract: OT2-08-02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark E Robson
    676 Robson